These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27385050)

  • 1. The effects of cytosine methylation on general transcription factors.
    Jin J; Lian T; Gu C; Yu K; Gao YQ; Su XD
    Sci Rep; 2016 Jul; 6():29119. PubMed ID: 27385050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11).
    Inoue S; Oishi M
    Gene; 2005 Mar; 348():123-34. PubMed ID: 15777718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CpG methylation on DNA binding protein: molecular dynamics simulations of the homeodomain PITX2 bound to the methylated DNA.
    Yang SY; Yang XL; Yao LF; Wang HB; Sun CK
    J Mol Graph Model; 2011 Jun; 29(7):920-7. PubMed ID: 21498098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene.
    Pang RT; Lee LT; Ng SS; Yung WH; Chow BK
    Mol Endocrinol; 2004 Feb; 18(2):471-83. PubMed ID: 14645499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes.
    Rishi V; Bhattacharya P; Chatterjee R; Rozenberg J; Zhao J; Glass K; Fitzgerald P; Vinson C
    Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20311-6. PubMed ID: 21059933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone induces a putative repressor complex and chromatin modifications in the CRH promoter.
    Sharma D; Bhave S; Gregg E; Uht R
    Mol Endocrinol; 2013 Jul; 27(7):1142-52. PubMed ID: 23671328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NonO binds to the CpG island of oct4 promoter and functions as a transcriptional activator of oct4 gene expression.
    Park Y; Lee JM; Hwang MY; Son GH; Geum D
    Mol Cells; 2013 Jan; 35(1):61-9. PubMed ID: 23212346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation status of CpG sites and methyl-CpG binding proteins are involved in the promoter regulation of the mouse Xist gene.
    Allaman-Pillet N; Djemaï A; Bonny C; Schorderet DF
    Gene Expr; 1998; 7(2):61-73. PubMed ID: 9699479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
    Bhakat KK; Mitra S
    Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
    Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J
    J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosine methylation of mitochondrial DNA at CpG sequences impacts transcription factor A DNA binding and transcription.
    Dostal V; Churchill MEA
    Biochim Biophys Acta Gene Regul Mech; 2019 May; 1862(5):598-607. PubMed ID: 30807854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic Methylation of a Single Persistently Unmethylated CpG in the Promoter of the Vitellogenin Gene Abolishes Its Inducibility by Estrogen through Attenuation of Upstream Stimulating Factor Binding.
    Kallenberger L; Erb R; Kralickova L; Patrignani A; Stöckli E; Jiricny J
    Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31548262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2).
    Di Fiore B; Palena A; Felsani A; Palitti F; Caruso M; Lavia P
    Nucleic Acids Res; 1999 Jul; 27(14):2852-9. PubMed ID: 10390525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1.
    Pfeifer GP; Tanguay RL; Steigerwald SD; Riggs AD
    Genes Dev; 1990 Aug; 4(8):1277-87. PubMed ID: 2227409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics study of the recognition of dimethylated CpG sites by MBD1 protein.
    Bianchi C; Zangi R
    J Chem Inf Model; 2015 Mar; 55(3):636-44. PubMed ID: 25658035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.
    Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M
    Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for effects of CpA modifications on C/EBPβ binding of DNA.
    Yang J; Horton JR; Wang D; Ren R; Li J; Sun D; Huang Y; Zhang X; Blumenthal RM; Cheng X
    Nucleic Acids Res; 2019 Feb; 47(4):1774-1785. PubMed ID: 30566668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A consensus DNA recognition motif for two KDWK transcription factors identifies flexible-length, CpG-methylation sensitive cognate binding sites in the majority of human promoters.
    Burnett E; Christensen J; Tattersall P
    J Mol Biol; 2001 Dec; 314(5):1029-39. PubMed ID: 11743720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG-methylation regulates a class of Epstein-Barr virus promoters.
    Bergbauer M; Kalla M; Schmeinck A; Göbel C; Rothbauer U; Eck S; Benet-Pagès A; Strom TM; Hammerschmidt W
    PLoS Pathog; 2010 Sep; 6(9):e1001114. PubMed ID: 20886097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3.
    Aoyama T; Okamoto T; Nagayama S; Nishijo K; Ishibe T; Yasura K; Nakayama T; Nakamura T; Toguchida J
    J Biol Chem; 2004 Jul; 279(27):28789-97. PubMed ID: 15107420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.